Cargando…

Collagenous colitis and atezolizumab therapy: an atypical case

Immune checkpoint inhibitors such as anti-CTLA-4 (cytotoxic T-lymphocyte-associated protein 4), anti-PD-1 (programmed cell death protein 1), and PD-L1 (programmed cell death protein-ligand 1) are emerging drugs that have radically changed treatment and prognosis of different types of tumors. However...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gallo, Antonella, Talerico, Rosa, Novello, Luca, Giustiniani, Maria Cristina, D’Argento, Ettore, Bria, Emilio, Montalto, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886711/ https://www.ncbi.nlm.nih.gov/pubmed/33151423 http://dx.doi.org/10.1007/s12328-020-01276-4

Ejemplares similares

Long-term survivors with immunotherapy in advanced NSCLC: is ‘cure’ within reach?
por: Monteverdi, Sara, et al.
Publicado: (2020)

Oncogene-Addicted Non-Small-Cell Lung Cancer: Treatment Opportunities and Future Perspectives
por: Ferrara, Miriam Grazia, et al.
Publicado: (2020)

Refractory Fulminant Colitis Requiring Surgical Intervention in a Patient With Ulcerative Colitis on Atezolizumab Therapy for Small Cell Lung Cancer: An Atypical Case
por: Steiger, Stephanie, et al.
Publicado: (2022)

Blood serum amyloid A as potential biomarker of pembrolizumab efficacy for patients affected by advanced non-small cell lung cancer overexpressing PD-L1: results of the exploratory “FoRECATT” study
por: Di Noia, Vincenzo, et al.
Publicado: (2020)

Masaoka-Koga and TNM Staging System in Thymic Epithelial Tumors: Prognostic Comparison and the Role of the Number of Involved Structures
por: Chiappetta, Marco, et al.
Publicado: (2021)

Second wave of the COVID-19 pandemic: D-dimer levels are not so high anymore
por: Porfidia, Angelo, et al.
Publicado: (2021)

Clinical Stage III NSCLC Patients Treated with Neoadjuvant Therapy and Surgery: The Prognostic Role of Nodal Characteristics †
por: Chiappetta, Marco, et al.
Publicado: (2022)

Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer
por: Carbone, Carmine, et al.
Publicado: (2019)

Prognostic and predictive factors of eribulin efficacy in heavily pretreated patients affected by metastatic breast cancer: correlation with tumor biology and previous therapies
por: Rossi, Sabrina, et al.
Publicado: (2017)

Mesothelioma in Familial Mediterranean Fever With Colchicine Intolerance: A Case Report and Literature Review
por: Talerico, Rosa, et al.
Publicado: (2020)

Monoinstitutional real world experience in management of Vinflunine as second line therapy for transitional cell carcinoma of the urothelium
por: Schinzari, Giovanni, et al.
Publicado: (2018)

Efficacy of topical beta-blockers in the management of EGFR-inhibitor induced paronychia and pyogenic granuloma-like lesions: case series and review of the literature
por: Sollena, Pietro, et al.
Publicado: (2019)

Treating disease progression with osimertinib in EGFR-mutated non-small-cell lung cancer: novel targeted agents and combination strategies
por: Di Noia, V., et al.
Publicado: (2021)

Are TKIs favourable for the elderly with non-small-cell lung cancer?
por: Rossi, Sabrina, et al.
Publicado: (2016)

The Renaissance of KRAS Targeting in Advanced Non-Small-Cell Lung Cancer: New Opportunities Following Old Failures
por: Ferrara, Miriam Grazia, et al.
Publicado: (2021)

Unweaving the mitotic spindle: A focus on Aurora kinase inhibitors in lung cancer
por: Stefani, Alessio, et al.
Publicado: (2022)

Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future Opportunities
por: Ferrara, Miriam Grazia, et al.
Publicado: (2021)

Collagenous Colitis and Spondylarthropathy
por: Ben Abdelghani, Kaouther, et al.
Publicado: (2012)

Correlation between Thrombus Perviousness and Distal Embolization during Mechanical Thrombectomy in Acute Stroke
por: Pilato, Fabio, et al.
Publicado: (2023)

Anastrozole-related acute hepatitis with autoimmune features: a case report
por: Inno, Alessandro, et al.
Publicado: (2011)

ERCC1 expression affects outcome in metastatic pancreatic carcinoma treated with FOLFIRINOX: A single institution analysis
por: Strippoli, Antonia, et al.
Publicado: (2016)

Maintenance therapy in NSCLC: why? To whom? Which agent?
por: Novello, Silvia, et al.
Publicado: (2011)

Advanced atypical lung carcinoid tumour successfully treated with carboplatin, etoposide and atezolizumab: A case report
por: Yamamoto, Yoshihiro, et al.
Publicado: (2022)

Cancer Risk in Collagenous Colitis
por: Larsson, Johanna K., et al.
Publicado: (2019)

Collagenous Gastritis: An Atypical Presentation of a Rare Disease
por: Kagihara, Jaclyn E, et al.
Publicado: (2023)

Lack of autoantibodies against collagen and related proteins in collagenous colitis
por: JK, Larsson, et al.
Publicado: (2022)

Pseudomembranous Collagenous Colitis: A Case of Not-so-Microscopic Colitis
por: Grunwald, Douglas, et al.
Publicado: (2016)

A rare case of abdominal lymphadenopathy and fever
por: Gallo, Antonella, et al.
Publicado: (2022)

Adjuvant atezolizumab-bevacizumab after curative therapy for hepatocellular carcinoma
por: Kudo, Masatoshi
Publicado: (2023)

COVID-19-Induced Collagenous Colitis
por: Brennan, Gregory T.
Publicado: (2022)

Atypical clinical manifestations of amebic colitis.
por: Yoon, J. H., et al.
Publicado: (1991)

Human herpesvirus 8-associated colonic Kaposi’s sarcoma during vedolizumab treatment in ulcerative colitis: a case report and review of the literature
por: Papa, Valerio, et al.
Publicado: (2020)

Complete Remission of Advanced Hepatocellular Carcinoma in a Patient With Ulcerative Colitis Treated With Atezolizumab and Bevacizumab: A Case Report
por: Pentapati, Swetha, et al.
Publicado: (2023)

Atezolizumab plus bevacizumab versus sorafenib or atezolizumab alone for unresectable hepatocellular carcinoma: A systematic review
por: Ahmed, Faiza, et al.
Publicado: (2021)

SAT-475 New Breast Cancer Therapy Atezolizumab, Leads to Thyroiditis
por: Parimi, Joseph Theressa Nehu, et al.
Publicado: (2020)

Factors associated with the response to atezolizumab/bevacizumab combination therapy for hepatocellular carcinoma
por: Yano, Yoshihiko, et al.
Publicado: (2023)

Collagenous colitis and rheumatoid arthritis: is there a connection?
por: Wollheim, F, et al.
Publicado: (2003)

Neutrophilic dermatoses in a patient with collagenous colitis
por: Barco, Didac, et al.
Publicado: (2010)

Optimal management of collagenous colitis: a review
por: O’Toole, Aoibhlinn
Publicado: (2016)

Automated image analysis in the study of collagenous colitis
por: Fiehn, Anne-Marie Kanstrup, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_dd8a53q2ac9k2t3nb493e75hik